BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Parsi MA. Obesity and cholangiocarcinoma. World J Gastroenterol 2013; 19(4): 457-462 [PMID: 23382624 DOI: 10.3748/wjg.v19.i4.457]
URL: https://www.wjgnet.com/1007-9327/full/v19/i4/457.htm
Number Citing Articles
1
Baiyu Yang, Jessica L. Petrick, Scott P. Kelly, Barry I. Graubard, Neal D. Freedman, Katherine A. McGlynn. Adiposity across the adult life course and incidence of primary liver cancer: The NIH‐AARP cohortInternational Journal of Cancer 2017; 141(2): 271 doi: 10.1002/ijc.30737
2
Akinobu Takaki, Seiji Kawano, Daisuke Uchida, Masahiro Takahara, Sakiko Hiraoka, Hiroyuki Okada. Paradoxical Roles of Oxidative Stress Response in the Digestive System before and after CarcinogenesisCancers 2019; 11(2): 213 doi: 10.3390/cancers11020213
3
Sung Soo Roh, Jae Soo Kim, Sung Cheol Yim. The Efficacy of Eriobotryae Folium Pharmacopuncture on Local Fat of High Fat Diet Induced Obesity Mice※The Acupuncture 2013; 30(3): 15 doi: 10.13045/acupunct.2013002
4
Firas Baidoun, Muhammad Talal Sarmini, Zahi Merjaneh, Muhamad Alhaj Moustafa. Controversial risk factors for cholangiocarcinomaEuropean Journal of Gastroenterology & Hepatology 2022; 34(3): 338 doi: 10.1097/MEG.0000000000002313
5
Daisuke Uchida, Akinobu Takaki, Hisashi Ishikawa, Yasuko Tomono, Hironari Kato, Koichiro Tsutsumi, Naofumi Tamaki, Takayuki Maruyama, Takaaki Tomofuji, Ryuichiro Tsuzaki, Tetsuya Yasunaka, Kazuko Koike, Hiroshi Matsushita, Fusao Ikeda, Yasuhiro Miyake, Hidenori Shiraha, Kazuhiro Nouso, Ryuichi Yoshida, Yuzo Umeda, Susumu Shinoura, Takahito Yagi, Toshiyoshi Fujiwara, Manabu Morita, Masaki Fukushima, Kazuhide Yamamoto, Hiroyuki Okada. Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinomaFree Radical Research 2016; 50(7): 732 doi: 10.3109/10715762.2016.1172071
6
Shahid A. Khan, Simona Tavolari, Giovanni Brandi. Cholangiocarcinoma: Epidemiology and risk factorsLiver International 2019; 39(S1): 19 doi: 10.1111/liv.14095
7
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control StudyPLoS ONE 2013; 8(7): e69981 doi: 10.1371/journal.pone.0069981
8
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open questionWorld Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
9
彬彬 彭. Research Progress on Risk Factors of CholangiocarcinomaAdvances in Clinical Medicine 2023; 13(03): 4025 doi: 10.12677/ACM.2023.133578
10
Darrian Reyes, Nivetha Ganesan, Paolo Boffetta, Ismail Labgaa. Arsenic-contaminated drinking water and cholangiocarcinomaEuropean Journal of Cancer Prevention 2023; 32(1): 10 doi: 10.1097/CEJ.0000000000000740
11
Chaitanya R. Churi, Rachna Shroff, Ying Wang, Asif Rashid, HyunSeon C. Kang, Jacqueline Weatherly, Mingxin Zuo, Ralph Zinner, David Hong, Funda Meric-Bernstam, Filip Janku, Christopher H. Crane, Lopa Mishra, Jean-Nicholas Vauthey, Robert A. Wolff, Gordon Mills, Milind Javle, Chad Creighton. Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic ImplicationsPLoS ONE 2014; 9(12): e115383 doi: 10.1371/journal.pone.0115383
12
Yi‐Te Lee, Jasmine J. Wang, Michael Luu, Mazen Noureddin, Nicholas N. Nissen, Tushar C. Patel, Lewis R. Roberts, Amit G. Singal, Gregory J. Gores, Ju Dong Yang. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United StatesHepatology 2021; 74(5): 2622 doi: 10.1002/hep.32007
13
Guo-Qiang Pan, Zhao-Ru Dong, Tao Li. A Novel Insight into Controversial Risk Factors of Intrahepatic Cholangiocarcinoma: A Mendelian Randomization StudySSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4149830
14
Usman Saeed, Marie Nordsletten, Tor Å. Myklebust, Trude E. Robsahm, Bjørn Møller, Bjørn Steen Skålhegg, Tom Mala, Sheraz Yaqub. Cancer risk and survival according to body mass index in hepatobiliary malignancies: a nationwide registry-based cohort studyHPB 2023; 25(11): 1382 doi: 10.1016/j.hpb.2023.07.882
15
Rikita I. Hatia, Madhulika Eluri, Ernest T. Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby, Ahmed Abdelhakeem, Reham Abdel-Wahab, Ping Chang, Asif Rashid, Prasun K. Jalal, Christopher I. Amos, Younghun Han, Tannaz Armaghany, Rachna T. Shroff, Donghui Li, Milind Javle, Manal M. Hassan. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with CholangiocarcinomaCancer Epidemiology, Biomarkers & Prevention 2023; 32(10): 1338 doi: 10.1158/1055-9965.EPI-23-0388
16
Amartej Merla, Kenneth G. Liu, Lakshmi Rajdev. Targeted Therapy in Biliary Tract CancersCurrent Treatment Options in Oncology 2015; 16(10) doi: 10.1007/s11864-015-0366-0
17
Yongjun Liu, Matthew M. Yeh. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challengesHuman Pathology 2023; 132: 158 doi: 10.1016/j.humpath.2022.06.012
18
Thomas C. Wirth, Arndt Vogel. Surveillance in cholangiocellular carcinomaBest Practice & Research Clinical Gastroenterology 2016; 30(6): 987 doi: 10.1016/j.bpg.2016.11.001
19
Ludovica Ceci, Tianhao Zhou, Ilaria Lenci, Vik Meadows, Lindsey Kennedy, Ping Li, Burcin Ekser, Martina Milana, Wenjun Zhang, Chaodong Wu, Keisaku Sato, Sanjukta Chakraborty, Shannon S. Glaser, Heather Francis, Gianfranco Alpini, Leonardo Baiocchi. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma DevelopmentCancers 2022; 14(6): 1442 doi: 10.3390/cancers14061442
20
Charupong Saengboonmee, Wunchana Seubwai, Chaisiri Wongkham, Sopit Wongkham. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinomaCancer Epidemiology 2015; 39(3): 274 doi: 10.1016/j.canep.2015.04.002